Skip to content

Photoactivated liquid-liquid phase separation-based cascade CRISPR/Cas12a electrochemical platform for sensitive small extracellular vesicles detection.

Aug 2026 · Talanta: The International Journal of Pure and Applied Analytical Chemistry · Vol 312 Pt A, pp. 130374 · 0 citations · 47 references
Medicine

TL;DR

An electrochemical platform based on the photoactivated liquid-liquid phase separation cascaded Cas12a amplification (PL-cCas12a) for ultrasensitive and specific detection of sEVs surface proteins and represents a promising tool for non-invasive early cancer diagnosis.

Abstract

Small extracellular vesicles (sEVs) have emerged as promising liquid biopsy biomarker for gastric cancer (GC) diagnosis. However, profiling sEVs surface proteins in complex clinical matrices remains challenging by limited sensitivity and high background interference. In this study, we developed an electrochemical platform based on the photoactivated liquid-liquid phase separation cascaded Cas12a amplification (PL-cCas12a) for ultrasensitive and specific detection of sEVs surface proteins. The rationally designed system enables precise spatiotemporal control over the reaction. Photoactivation ensures precise reaction initiation. The spatially confined microenvironment accelerate reaction efficiency by local substrates enrichment and suppresses non-specific trans-cleavage leakage via steric hindrance. The PL-cCas12a platform achieved the limit of detection (LOD) as low as 3.95 × 103 particles/μL with negligible background leakage. By integrating the aptamers targeting GC-associated sEV surface proteins, this platform accurately discriminated GC patients from healthy donors (AUC = 0.912). Therefore, this platform represents a promising tool for non-invasive early cancer diagnosis.

View source

Similar papers

Oct 2026

Temperature-responsive PDDNFs@QDs integrating simplified isolation for efficient tumor-derived small extracellular vesicles analysis enables breast cancer diagnosis and subtyping.

Multiplexed small extracellular vesicles (sEVs) biomarker detection holds great promise for breast cancer diagnosis and subtyping; however, its clinical application is often hampered by the complex isolation and detection processes. Herein, we propose a temperature-responsive sensing platform (PDDNFs@QDs) utilizing pol...

Xiang-Yue Meng, Zhi-Hao Zhang, Peng-Jun Jiang et al. · 0 citations
Open access Aug 2026

Cascade-coupled colorimetric-fluorescent dual-signal detection of EGFR-positive extracellular vesicles via bifunctional MOF@Pt nanozyme integrated with a CHA-CRISPR system.

A platform that integrates a bifunctional nanozyme system with a CHA-CRISPR/Cas12a cascade, achieving selective isolation and ultrasensitive detection of EGFR-positive glioma-derived EVs and offers a potentially adaptable framework for cascade-coupled dual-signal biosensing is developed.

Yan Wang, Bo-Ya Xu, Zehan Zeng et al. · 0 citations
Sep 2026

Precise Mutation Detection in Low-Abundance Tumor-Derived Extracellular Vesicles via Microfluidic Immunomagnetic Reversible Affinity Capture.

The MIRACLE platform is developed, an integrated system combining microfluidic magneto-controllable reversible affinity capture with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for efficient, multiplexed detection of tumor-derived EV DNA mutations.

Xing Xu, Shan-Shan Liang, Heng-Kai Chen et al. · 0 citations
Oct 2026

Bifunctional CuPt Nanoclusters and DSN-Mediated Target Recycling Enabled Dual-Mode OPECT/Colorimetric Biosensing for Ultrasensitive and Wide-Range Detection of miRNA-21.

MicroRNA-21 (miRNA-21) is an important cancer biomarker that requires highly sensitive and reliable detection across a broad concentration range. Here, we report a dual-mode biosensing platform that integrates organic photoelectrochemical transistor (OPECT) amplification with nanozyme-assisted colorimetric transduction...

Hong-Tao Chen, Xue Wang, Jia-He Chen et al. · 0 citations
Sep 2026

Cascade-Amplified Microfluidic Detection of Tumor Biomarkers via Metal-DNA Nanospheres Activating CRISPR-Cas12a Assay.

A highly efficient signal-transduction strategy utilizing Fe-coordinated DNA nanospheres (FDNSs)─a programmable, metal-nucleic acid assembly─as a high-capacity DNA reservoir for amplified biomarker sensing, providing a robust and portable solution for cancer screening in resource-limited settings.

Wen-Jian Zhao, Xiao-Wei Luan, Wen-Xiu Long et al. · 0 citations
Aug 2026

A cascaded CHA-CRISPR/Cas12a photoelectrochemical platform enabled by S-scheme Bi2WO6/BiOBr for piR-823 detection.

This work developed a cascaded CHA-CRISPR/Cas12a photoelectrochemical sensing platform enabled by an S-scheme Bi2WO6/BiOBr heterojunction for the reliable detection of piR-823 and offers guidance for the rational construction of S-scheme heterojunctions in high-performance PEC biosensors.

Xia-Wen Lin, Peng Ye, Yang-Yang Ding et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.